News
Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...
She urges the government to invest in more biotechnology laboratories, emphasizing their importance in training, especially conducting experiments and inspiring the next generation of scientists.
The high costs of material and laboratory infrastructure were identified as critical barriers during the incubation of five biotech spinouts Stellenbosch University (SU) has announced the opening ...
Partner presentations reinforce ability of proprietary Azymetric™ platform to develop clinically validated therapeutic antibodiesLong-term outcomes and survival data for Ziihera® (zanidatamab-hrii), ...
“I talked about it with agents. There was a full-blown bomb lab in this guy’s house.” “I know how powerful and destructive IEDs can be,” added Bickel, who said he was an Army veteran ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...
Bora Biologics, a subsidiary of Tanvex Biopharma born out of a spinoff from Bora Pharmaceuticals, is expanding CDMO operations at its San Diego facility. The new project will add 8,075 square feet of ...
In the life sciences industry, companies face a unique journey from lab to market. The path demands a banking partner with deep industry expertise, a long-term commitment to relationships ...
The report values San Francisco-based Nektar at $17 billion thanks to its multi-billion dollar deal with Bristol-Myers Squibb in February, the largest single product deal in biotech history.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results